Currently out of the existing stock ratings of Jason Gerberry, 218 are a BUY (66.67%), 31 are a SELL (9.48%), 78 are a HOLD (23.85%).

Jason Gerberry

Work Performance Price Targets & Ratings Chart

Analyst Jason Gerberry, currently employed at BAML, carries an average stock price target met ratio of 66.17% that have a potential upside of 33.51% achieved within 333 days.

Jason Gerberry’s has documented 656 price targets and ratings displayed on 64 stocks. The coverage is on Healthcare, Industrials sectors.

Most recent stock forecast was given on LLY, Eli Lilly and Company at 10-Jul-2026.

Wall Street Analyst Jason Gerberry

Analyst best performing recommendations are on PROK (PROKIDNEY CORP.).
The best stock recommendation documented was for PROK (PROKIDNEY CORP.) at 6/30/2025. The price target of $1 was fulfilled within 8 days with a profit of $0.41 (69.49%) receiving and performance score of 86.86.

Average potential price target upside

of $62.11 (34.32%) on KRTX (KARUNA THERAPEUTICS).
of $47.85 (37.49%) on JAZZ (JAZZ PHARMACEUTICALS PLC).
of $35.58 (53.79%) on ABBV (ABBVIE).

ABBV AbbVie AGN Allergan plc ALKS Alkermes Plc BHC Bausch Health Companies BLUE Bluebird bio BYSI BeyondSpring ENDP Endo International PLC FGEN FibroGen GLPG Galapagos NV ADR HZNP Horizon Pharma PLC IONS Ionis Pharmaceuticals JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MRTX Mirati Ther MYL Viatris PCVX Vaxcyte TARS Tarsus Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ALLO Allogene Therapeutics BMY Bristol-Myers Squibb Company HRTX Heron Therapeuti MNTA Momenta Pharmaceuticals PFE Pfizer AKRX Akorn ARNA Arena Pharmaceuticals AVDL Avadel Pharmaceuticals PLC CORI Corium International KRTX Karuna Therapeutics PRGO Perrigo Company PLC DICE Dice Molecules Holdings LLC FWP Forward Pharma A S VTRS Viatris OGN Organon ACLX Arcellx AERI Aerie Pharmaceuticals AMTI Applied Molecular Transport CARA Cara Therapeutic LYRA Lyra Therapeutics CHRS Coherus BioSciences RLAY Relay Therapeutics XENE Xenon Pharmaceuticals AXSM Axsome Therapeutics ARWR Arrowhead Pharmaceuticals HRMY Harmony Biosciences Holdings ITCI Intracellular Th AMPH Amphastar P CPRX Catalyst Pharmaceuticals EXEL Exelixis IMVT Immunovant OCS Oculis Holding AG Ordinary shares PROK ProKidney Corp. BHVN Biohaven Pharmaceutical Holding Co Ltd KALV Kalvista Pharmaceuticals NBRV Nabriva Therapeutics AG SESN Sesen Bio VRCA Verrica Pharmaceuticals ASRT Assertio Therapeutics ACT Enact Holdings AER AerCap Holdings NV ARDX Ardelyx FG F&G Annuities & Life PCRX Pacira Pharmaceuticals

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Gary Nachman (RAYMOND JAMES)